Alerts will be sent to your verified email
Verify Email
AKUMS
|
Akums Drugs & Pharma
|
FDC
|
Marksans Pharma
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Pharmaceutical Sector
|
|||
|
DMF Filingsby API
|
20.0 . | n/a | n/a |
|
R&D as a % of Total Sales
|
0.7 % | 2.22 % | 2.0 % |
|
Financials
|
|||
|
5 yr Average ROE
|
-0.59 % | 12.9 % | 17.57 % |
|
5yr average Equity Multiplier
|
3.58 | 1.57 | 1.33 |
|
5yr Average Asset Turnover Ratio
|
1.18 | 0.55 | 0.9 |
|
5yr Avg Net Profit Margin
|
1.67 % | 15.2 % | 14.56 % |
|
Price to Book
|
2.31 | 3.24 | 3.02 |
|
P/E
|
20.57 | 27.48 | 21.26 |
|
5yr Avg Cash Conversion Cycle
|
41.09 Days | -13.89 Days | 71.65 Days |
|
Inventory Days
|
60.56 Days | 61.89 Days | 89.77 Days |
|
Days Receivable
|
71.09 Days | 18.98 Days | 65.99 Days |
|
Days Payable
|
82.93 Days | 89.17 Days | 88.81 Days |
|
5yr Average Interest Coverage Ratio
|
6.25 | 90.41 | 38.03 |
|
5yr Avg ROCE
|
6.7 % | 13.8 % | 21.95 % |
|
5yr Avg Operating Profit Margin
|
6.07 % | 17.7 % | 20.32 % |
|
5 yr average Debt to Equity
|
0.43 | 0.0 | 0.02 |
|
5yr CAGR Net Profit
|
22.48 % | -2.41 % | 10.03 % |
|
5yr Average Return on Assets
|
1.78 % | 8.22 % | 13.19 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
75.26 % | 69.66 % | 43.87 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | 0.16 % | -4.38 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
1.55 % | 1.1 % | 2.6 % |
|
Akums Drugs & Pharma
|
FDC
|
Marksans Pharma
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
|
Operating Profit Break-Up
|
Operating Profit Break-Up
|
-
|
-
|
|
Asset Break-Up - Segment Wise
|
Asset Break-Up - Segment Wise
|
-
|
-
|